2024 Annual Meeting of the American Thyroid Association

ATA AT HOME - Post-meeting on-demand session recordings

• Plenary: Year in Thyroidology 
• Oral Abstract: Clinical – Thyroid Cancer 
• Debate: What is the Best Way to Monitor Primary Hypothyroidism After Therapy is Initiated? 
• Van Meter & Braverman Award Lectures 
• Considerations in Concurrent Thyroid and Parathyroid Disease Management 
• Controversies in Treatment of Intermediate Risk Thyroid Cancer with RAI 
• Galton & Ingbar Award Lectures 
• Evolving Concepts in the Management of Hyperthyroidism 
• Sawin Lecture – Landmark Discoveries in maternal-Fetal Thyroid Disease Over the Past Century 
• Beyond the Scar Navigating Fertility, Bone and Cardiac Health in Thyroid Cancer Survivors
• Concerns and Obstacles to AI Adoption in Thyroidology
• T4/T3 Combination Therapy for Hypothyroidism – Where are We Now? 
• Neoadjuvant Therapy for Thyroid Cancer
• Oral Abstract: Basic & Translational – Thyroid Cancer

Continuing Medical Education Credit Information 

Accreditation 

The American Thyroid Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

AMA PRA Category 1 Credits™ 

The American Thyroid Association designates this live activity for a maximum of 14 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Disclosure Information 

In accordance with the ACCME Accreditation Criteria, the American Thyroid Association ensures that anyone in a position to control the content of the educational activity (planners/speakers/authors/discussants/moderators) disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”) held in the last 24 months. Please note that first authors were required to collect and submit disclosure information on behalf of all other authors/contributors, if applicable. Click here to see the COI disclosures.